Nchi: Australia
Lugha: Kiingereza
Chanzo: Department of Health (Therapeutic Goods Administration)
thiamine hydrochloride, Quantity: 5.4 mg; riboflavin, Quantity: 3.6 mg; nicotinamide, Quantity: 14.4 mg; calcium pantothenate, Quantity: 11.7 mg (Equivalent: pantothenic acid, Qty 10.7 mg); pyridoxine hydrochloride, Quantity: 4.5 mg (Equivalent: pyridoxine, Qty 3.7 mg); cyanocobalamin, Quantity: 0.01 mg; Biotin, Quantity: 0.09 mg; inositol, Quantity: 5.4 mg; retinol palmitate, Quantity: 641.2 microgram (Equivalent: vitamin A, Qty 1165.82 IU); d-alpha-tocopheryl acid succinate, Quantity: 5.4 mg; choline bitartrate, Quantity: 4.5 mg; ferrous fumarate, Quantity: 34.5 mg (Equivalent: iron, Qty 11.3 mg); zinc oxide, Quantity: 9 mg (Equivalent: zinc, Qty 5.9 mg); potassium iodide, Quantity: 0.09 mg (Equivalent: iodine, Qty 0.0688 mg); manganese sulfate monohydrate, Quantity: 1.4 mg (Equivalent: manganese, Qty 0.455 mg); selenomethionine, Quantity: 0.1875 mg (Equivalent: selenium, Qty 0.075 mg); magnesium oxide, Quantity: 112.5 mg (Equivalent: magnesium, Qty 67.5 mg); calcium carbonate, Quantity: 300 mg (Equivalent: calcium, Qty 120 mg); levocarnitine hydrochloride, Quantity: 15.75 mg; ascorbic acid, Quantity: 75 mg; folic acid, Quantity: 0.25 mg; fructooligosaccharides, Quantity: 50 mg; taurine, Quantity: 15 mg; hydrolysed collagen, Quantity: 50 mg; colecalciferol, Quantity: 0.009 mg
Ferngrove Pharmaceuticals Australia Pty Ltd
Tablet, film coated
Excipient Ingredients: microcrystalline cellulose; colloidal anhydrous silica; magnesium stearate; titanium dioxide; croscarmellose sodium; crospovidone; povidone; hypromellose; macrogol 400; iron oxide yellow; maltodextrin; maize starch; calcium hydrogen phosphate dihydrate; iron oxide red; vanillin; silicon dioxide; dl-alpha-tocopherol; sucrose; hydrolysed gelatin; hydrogenated soya oil
Oral
Visual Identification: Pink coloured film coated tablet with break bar on one side; Container Type: Bottle
Listed (Export Only)
2021-09-30